Publications by authors named "Z Berger"

Rationale: The Joint Commission emphasizes the importance of cultural competence and effective communication in quality medical care, particularly during end-of-life (EOL), when decisions are influenced by diverse cultural and religious backgrounds. For Orthodox Jewish patients, the philosophical framework used for EOL decision-making may conflict with that used in traditional Western medical ethics. In this paper, we explore the complexities of EOL decision-making for devout Jewish patients and highlight how approaches may differ from a Western ethical framework.

View Article and Find Full Text PDF
Article Synopsis
  • Paediatric Multisystem Inflammatory Syndrome (PIMS-TS) emerged during the COVID-19 pandemic, with limited research on the psychological needs of affected children and young people (CYP) after hospital admission.
  • A study of 121 CYP and their parents/caregivers in London showed that 23.3% of CYP were at risk for traumatic stress, while 40.5% of parents scored above the clinical threshold for trauma.
  • The findings emphasize the need for proactive screening of trauma and emotional health in both CYP and their families, highlighting the interconnectedness of their care.
View Article and Find Full Text PDF

Purpose: Both breast reduction surgery (BRS) in adolescent girls and chest masculinization surgery (CMS) transgender and nonbinary (TGNB) individuals improve physical discomfort and psychological well-being. Nonetheless, CMS in adolescents is highly contested due to concerns regarding safety and capacity for consent. Here, we compare both procedures to quantify trends in incidence, minimum age, and surgical outcomes.

View Article and Find Full Text PDF

Introduction: Spinal muscular atrophy (SMA) is a rare, autosomal recessive, neuromuscular disease that leads to progressive muscular weakness and atrophy. Nusinersen, an antisense oligonucleotide, was approved for SMA in China in February 2019. We report interim results from a post-marketing surveillance phase 4 study, PANDA (NCT04419233), that collects data on the safety, efficacy, and pharmacokinetics of nusinersen in children with SMA in routine clinical practice in China.

View Article and Find Full Text PDF